Radiation oncology firm Elekta announced that Auckland Radiation Oncology Centre in New Zealand launched its stereotactic radiotherapy program in November, using Elekta's Synergy system upgraded with its Agility technology.
The center's first patient was a 61-year-old man who was given the first of 10 stereotactic radiotherapy treatments, thus avoiding surgery to remove residual tumor from a previous operation, according to Elekta.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
